Cammisotto, V.; Baratta, F.; Castellani, V.; Bartimoccia, S.; Nocella, C.; D’Erasmo, L.; Cocomello, N.; Barale, C.; Scicali, R.; Di Pino, A.;
et al. Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. Int. J. Mol. Sci. 2021, 22, 7193.
https://doi.org/10.3390/ijms22137193
AMA Style
Cammisotto V, Baratta F, Castellani V, Bartimoccia S, Nocella C, D’Erasmo L, Cocomello N, Barale C, Scicali R, Di Pino A,
et al. Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. International Journal of Molecular Sciences. 2021; 22(13):7193.
https://doi.org/10.3390/ijms22137193
Chicago/Turabian Style
Cammisotto, Vittoria, Francesco Baratta, Valentina Castellani, Simona Bartimoccia, Cristina Nocella, Laura D’Erasmo, Nicholas Cocomello, Cristina Barale, Roberto Scicali, Antonino Di Pino,
and et al. 2021. "Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways" International Journal of Molecular Sciences 22, no. 13: 7193.
https://doi.org/10.3390/ijms22137193
APA Style
Cammisotto, V., Baratta, F., Castellani, V., Bartimoccia, S., Nocella, C., D’Erasmo, L., Cocomello, N., Barale, C., Scicali, R., Di Pino, A., Piro, S., Del Ben, M., Arca, M., Russo, I., Purrello, F., Carnevale, R., Violi, F., Pastori, D., & Pignatelli, P.
(2021). Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. International Journal of Molecular Sciences, 22(13), 7193.
https://doi.org/10.3390/ijms22137193